This is to inform you that as per Regulation 15(2) of SEBI (LODR) Regulations, 2015, Corporate Governance and the above mentioned provisions such as Regulation 23(9) of SEBI (LODR) Regulations, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivanza Biosciences has informed BSE that it is exempt from submitting Related Party Transaction disclosures under SEBI Regulation 23(9) for Q4 and FY 2025-26. The exemption applies because the company falls below the thresholds set by Regulation 15(2) — its paid-up equity share capital is Rs. 4 crore and net worth is Rs. 4.02 crore, both below the Rs. 10 crore and Rs. 25 crore limits respectively. The company is a micro-cap listed entity (BSE Scrip Code: 530057) headquartered in Ahmedabad. The Managing Director Jayendra Mehta signed the filing dated 7th May 2026.
No direct impact on shareholders or stock price — this is a routine regulatory compliance filing confirming the company's exemption from a disclosure requirement due to its small size. The company remains bound to comply if it crosses the thresholds in future.